NASDAQ:POAI Predictive Oncology (POAI) Stock Price, News & Analysis $7.68 -0.73 (-8.68%) As of 10/16/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsNews and TrendsSEC Filings About Predictive Oncology Stock (NASDAQ:POAI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Predictive Oncology alerts:Sign Up Key Stats Today's Range$7.64▼$8.6150-Day Range$8.01▼$12.9952-Week Range$0.71▼$16.54Volume335,544 shsAverage Volume473,545 shsMarket Capitalization$26.07 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Predictive Oncology Inc. (NASDAQ: POAI) is a biotechnology company focused on applying artificial intelligence and machine learning to oncology drug discovery and precision medicine. The company combines computational tools with biological data to help identify promising therapeutic candidates and predict how individual tumors may respond to specific treatments. Its technology platform is built around a proprietary collection of tumor samples and associated clinical and drug-response information. Predictive Oncology uses this data to support pharmaceutical and biotechnology companies in evaluating drug candidates, identifying potential biomarkers, and developing more targeted cancer therapies. The company has also offered tumor-profiling and drug-response testing through its Helomics subsidiary and related operations. Predictive Oncology’s business has evolved from earlier precision-medicine and cancer-diagnostics activities toward an artificial-intelligence-driven drug discovery model. Its operations and research collaborations have been based primarily in the United States, although the company’s platform is intended to support pharmaceutical and biotechnology partners more broadly. Specific details about its current leadership structure and geographic commercial reach may change over time.AI Generated. May Contain Errors. Read More Receive POAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Predictive Oncology and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. POAI Stock News HeadlinesPredictive Oncology (NASDAQ:POAI) Shares Cross Above 50-Day Moving Average - What's Next?October 6, 2026 | americanbankingnews.comPredictive Oncology announces name change to Axe ComputeDecember 12, 2025 | msn.comDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.October 17 at 1:00 AM | Stansberry Research (Ad)Predictive Oncology rebrands to Axe Compute Inc.December 11, 2025 | msn.comPredictive Oncology Regains Nasdaq ComplianceDecember 2, 2025 | tipranks.comPredictive Oncology regains compliance with Nasdaq minimum stockholder equityDecember 2, 2025 | msn.comPredictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity RequirementDecember 2, 2025 | markets.businessinsider.comPredictive Oncology Regains Nasdaq Compliance with InvestmentsNovember 20, 2025 | tipranks.comSee More Headlines POAI Stock Analysis - Frequently Asked Questions How have POAI shares performed this year? Predictive Oncology's stock was trading at $7.15 at the beginning of the year. Since then, POAI stock has increased by 7.4% and is now trading at $7.68. How were Predictive Oncology's earnings last quarter? Predictive Oncology Inc. (NASDAQ:POAI) announced its earnings results on Friday, November, 14th. The medical instruments supplier reported ($4.52) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.35) by $3.17. The medical instruments supplier had revenue of $0 million for the quarter, compared to analyst estimates of $1.50 million. Predictive Oncology had a negative trailing twelve-month return on equity of 732.73% and a negative net margin of 5,065.23%. Read the conference call transcript. When did Predictive Oncology's stock split? Shares of Predictive Oncology reverse split on Tuesday, September 30th 2025.The 1-15 reverse split was announced on Thursday, September 25th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 29th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. How do I buy shares of Predictive Oncology? Shares of POAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Predictive Oncology own? Based on aggregate information from My MarketBeat watchlists, some other companies that Predictive Oncology investors own include FuelCell Energy (FCEL), Tesla (TSLA), NVIDIA (NVDA), Plug Power (PLUG), AMC Entertainment (AMC), Bionano Genomics (BNGO) and Lithium Americas (LAC). Company Calendar Last Earnings11/14/2025Today10/17/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorTechnology Industry IT Services Sub-IndustryInternet Services & Infrastructure Current SymbolNASDAQ:POAI CIK1446159 Webwww.precisiontherapeutics.com Phone(651) 389-4800FaxN/AEmployees30Year Founded2002Profitability EPS (Trailing Twelve Months)($13.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$12.66 million Net Margins-5,065.23% Pretax Margin-5,082.34% Return on Equity-732.73% Return on Assets-235.55% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual Sales$1.66 million Price / Sales15.66 Cash FlowN/A Price / Cash FlowN/A Book Value($0.46) per share Price / Book-16.70Miscellaneous Outstanding Shares3,394,000Free Float3,353,000Market Cap$26.07 million OptionableNot Optionable Beta1.35 Social Links 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:POAI) was last updated on 10/16/2026 by MarketBeat.com Staff. From Our PartnersTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...Banyan Hill Publishing | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going t...Decentralized Masters | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | Sponsored100% overnight gains?Rumors are circulating that Elon Musk is preparing to acquire three publicly traded companies. Dr. Mark Sko...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Predictive Oncology With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free POAI Stock Alerts